Investing.com - Qiagen (NYSE:QGEN) reported on Tuesday second quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Qiagen announced earnings per share of $0.47 on revenue of $377.1M. Analysts polled by Investing.com anticipated EPS of $0.44 on revenue of $388.54M.
Qiagen shares are up 35% from the beginning of the year, still down 4.07% from its 52 week high of $42.98 set on July 30. They are outperforming the STOXX 600 which is down 12.61% from the start of the year.
Qiagen follows other major Healthcare sector earnings this month
Qiagen's report follows an earnings beat by Siemens Healthineers on Monday, who reported EPS of $0.3 on revenue of $3.31B, compared to forecasts EPS of $0.27 on revenue of $3.36B.
Fresenius SE had beat expectations on July 30 with second quarter EPS of $0.74 on revenue of $8.92B, compared to forecast for EPS of $0.73 on revenue of $9.04B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar